N,N-dimethylarginine

Known as: N(G1),N(G1)-dimethylarginine, N(G)-dimethylarginine, N(5)-((dimethylamino)iminomethyl)-L-ornithine 
A methylated derivative of L-arginine that is a competitive inhibitor of nitric oxide synthase (NOS). Asymmetric dimethylarginine (ADMA) is formed… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1971-2018
010020019712018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
OBJECTIVE Plasma levels of an endogenous nitric oxide (NO) synthase inhibitor, asymmetric dimethylarginine (ADMA), are elevated… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND NO is a major regulator of cardiovascular physiology that reduces vascular and cardiac contractility. Accumulating… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND An endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), is elevated in patients with… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), may be related to reduced… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Hyperhomocysteinemia is a putative risk factor for cardiovascular disease, which also impairs endothelium-dependent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Asymmetrical dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor. It is formed by protein arginine N… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 7
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS). Plasma levels of ADMA… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthase. Because… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1996
Highly Cited
1996
1. Dimethylarginine dimethylaminohydrolase (DDAH), an enzyme that metabolizes the endogenous nitric oxide synthase inhibitors NG… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Nitric oxide (NO), synthesised from L-arginine, contributes to the regulation of blood pressure and to host defence. We describe… (More)
Is this relevant?